Ticker >

Anuh Pharma share price

Anuh Pharma Ltd.

BSE: 506260 SECTOR: Pharmaceuticals & Drugs  21k   109   17

230.05
+2.70 (1.19%)
BSE: Today, 10:53 AM

Price Summary

Today's High

₹ 236

Today's Low

₹ 229

52 Week High

₹ 238.8

52 Week Low

₹ 77

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1152.83 Cr.

Enterprise Value

1146.17 Cr.

No. of Shares

5.01 Cr.

P/E

21.22

P/B

4.18

Face Value

₹ 5

Div. Yield

0.88 %

Book Value (TTM)

₹  55.05

CASH

6.65 Cr.

DEBT

0 Cr.

Promoter Holding

69.94 %

EPS (TTM)

₹  10.84

Sales Growth

8.39%

ROE

15.9 %

ROCE

21.05%

Profit Growth

18.38 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year8.39%
3 Year19.78%
5 Year17.25%

Profit Growth

1 Year18.38%
3 Year36.25%
5 Year16.99%

ROE%

1 Year15.9%
3 Year15.71%
5 Year14.15%

ROCE %

1 Year21.05%
3 Year20.04%
5 Year18.31%

Debt/Equity

0

Price to Cash Flow

21.39

Interest Cover Ratio

64.6076644780919

CFO/PAT (5 Yr. Avg.)

0.903926580975006

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 69.94 0
Sep 2023 70.59 0
Jun 2023 70.59 0
Mar 2023 70.59 0
Dec 2022 70.59 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 36.2455303211203% for the Past 3 years.
  • The company has shown a good revenue growth of 19.7776501498916% for the Past 3 years.
  • The company has significantly decreased its debt by 3.111 Cr.
  • Company has been maintaining healthy ROCE of 20.0426321655783% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 64.6076644780919.
  • The company has an efficient Cash Conversion Cycle of 32.8043515764869 days.
  • The company has a high promoter holding of 69.94%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 138.73 157.31 161.48 149.53 172.1
Total Expenditure 126.3 143.08 147.51 131.57 148.11
Operating Profit 12.43 14.23 13.98 17.96 23.99
Other Income 2.11 1.04 3.47 2.15 3.66
Interest 0.03 0.02 0.02 0.09 0.14
Depreciation 2.43 2.41 2.01 2.15 2.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 12.08 12.84 15.41 17.88 25.31
Tax 2.77 3.22 3.66 4.04 6.19
Profit After Tax 9.31 9.62 11.75 13.84 19.11
Adjusted EPS (Rs) 1.86 1.92 2.35 2.76 3.81

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 320.66 306.96 431.96 486.65 527.49
Total Expenditure 290.7 283.73 386.84 439.18 475.68
Operating Profit 29.96 23.23 45.12 47.46 51.8
Other Income 4.7 4.21 10.54 5.2 6.11
Interest 0.6 1.26 2.03 1.58 0.75
Depreciation 1.66 7.03 15.08 11.96 9.7
Exceptional Items 0 0 0 0 0
Profit Before Tax 32.4 19.16 38.55 39.12 47.47
Tax 9.04 4.85 10.12 8.56 11.29
Net Profit 23.37 14.31 28.44 30.56 36.18
Adjusted EPS (Rs.) 4.66 2.85 5.67 6.1 7.22

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 12.53 12.53 25.06 25.06 25.06
Total Reserves 152.07 149.68 165.59 188.72 216.17
Borrowings 0 0 0 0 0
Other N/C liabilities -0.04 1.46 2.53 2.5 1.66
Current liabilities 74.8 162.71 139.47 130.91 161.34
Total Liabilities 239.37 326.37 332.64 347.17 404.21
Assets
Net Block 21.17 84.04 71.42 61.42 52.81
Capital WIP 33.85 0 0 0.1 0
Intangible WIP 0 0 0 0 0
Investments 30.03 13.7 20.37 21.21 39.68
Loans & Advances 2.13 2.68 2.62 2.2 4.11
Other N/C Assets 0 3 0.5 3.55 0
Current Assets 152.18 222.95 237.73 258.69 307.61
Total Assets 239.37 326.37 332.64 347.17 404.21
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 32.4 19.16 38.55 39.12 47.47
Adjustment -2.12 8.3 7.43 8.17 4.39
Changes in Assets & Liabilities -13.4 26.57 -54.98 -9.29 15.51
Tax Paid -9.76 -5.09 -9.73 -9.14 -13.47
Operating Cash Flow 7.12 48.93 -18.73 28.86 53.9
Investing Cash Flow 2.86 -76.53 52.2 -7.82 -43.48
Financing Cash Flow -6.51 22.17 -33.12 -19.45 -12.29
Net Cash Flow 3.47 -5.43 0.35 1.6 -1.87

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 70.59 70.59 70.59 70.59 69.94
aruna navnit shah 0.01 0.01 0.01 0.01 0.01
bharat nemchand shah 3.73 3.73 3.73 3.73 3.73
bharti bipin shah - - - - 19.43
bipin nemchand shah 6.21 6.21 6.21 6.21 6.21
bipin nemchand shah (huf)... - - - - 8.47
damyanti n shah 0.06 0.06 0.06 0.06 0.06
dina satish shah 2.22 2.22 2.22 2.22 2.22
gaurav satish shah 3.19 3.19 3.19 3.19 3.19
harshit bharat shah 0.50 0.50 0.50 0.50 0.50
hemant babubhai choksi 0.03 0.03 0.03 0.03 0.03
indu kishor mody 0.03 0.03 0.03 0.03 0.03
japosha trading llp 0.19 0.19 0.19 0.19 0.19
ketan lalit shah 0.48 0.48 0.48 0.48 0.48
kinjal siddharth jhaveri 0.81 0.81 0.81 0.81 0.81
kiran piyush shah 0.02 0.02 0.02 0.02 0.02
lalitkumar popatlal shah 8.81 8.81 8.81 8.81 8.81
madhurika narendra shah 0.01 0.01 0.01 0.01 0.01
mahesh kantilal shah 0.17 0.17 0.17 0.17 0.17
mrudula jayantilal shah 2.33 2.33 2.33 2.33 2.33
mrudula praful shah 0.12 0.12 0.12 0.12 0.12
mukesh kantilal shah 0.01 0.01 0.01 0.01 0.01
nina vijay shah 0.06 0.06 0.06 0.06 0.06
panna mahesh shah 0.20 0.20 0.20 0.20 0.20
praful kantilal shah 0.46 0.46 0.46 0.46 0.46
prafulla lalit shah 5.66 5.66 5.66 5.66 5.66
ritesh bipin shah 2.31 2.31 2.31 2.31 2.31
rohan mahesh shah 0.10 0.10 0.10 0.10 0.10
rupa paresh shah 0.01 0.01 0.01 0.01 0.01
samir jayantilal shah 1.72 1.72 1.72 1.72 1.72
surekha bharat shah 0.27 0.27 0.27 0.27 0.27
urvashi manoj sanghavi 0.01 0.01 0.01 0.01 0.01
vivek bipin shah 2.33 2.33 2.33 2.33 2.33
amisha kocha 0.14 0.14 0.14 0.14 -
bharati bipin shah 19.43 19.43 19.43 19.43 -
bijal kaushal shroff 0.22 0.22 0.22 0.22 -
bipin nemchand shah (hu... 8.48 8.48 8.48 8.48 -
riddhi kalapi shah 0.25 0.25 0.25 0.25 -
urmila k shah 0.03 0.03 0.03 0.03 -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 29.41 29.41 29.41 29.41 30.06
investor education and pr... 0.08 0.08 0.08 0.11 0.11

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Anuh Pharma submits investor presentation19 Feb 2024, 2:54PM Anuh Pharma - Quaterly Results9 Feb 2024, 4:32PM Anuh Pharma - Quaterly Results9 Feb 2024, 4:32PM Anuh Pharma - Quaterly Results9 Feb 2024, 4:32PM Anuh Pharma informs about proceedings of AGM 19 Aug 2023, 3:12PM Anuh Pharma - Quaterly Results11 Aug 2023, 4:31PM Anuh Pharma - Quaterly Results11 Aug 2023, 4:31PM Anuh Pharma informs about AGM25 Jul 2023, 12:46PM Anuh Pharma - Quaterly Results19 May 2023, 4:28PM Anuh Pharma - Quaterly Results19 May 2023, 4:28PM Anuh Pharma informs about certificate 4 May 2023, 1:05PM Anuh Pharma - Quaterly Results10 Feb 2023, 4:48PM Anuh Pharma - Quaterly Results10 Feb 2023, 4:48PM Anuh Pharma informs about confirmation certificate12 Jan 2023, 5:39PM Anuh Pharma informs about appointment of CS cum CO 7 Jan 2023, 12:13PM Anuh Pharma informs about closure of trading window 31 Dec 2022, 3:32PM Anuh Pharma informs about disclosure of related party transactions 15 Nov 2022, 5:18PM Anuh Pharma informs about outcome of board meeting 7 Nov 2022, 5:20PM Anuh Pharma - Quaterly Results7 Nov 2022, 3:32PM Anuh Pharma - Quaterly Results7 Nov 2022, 3:32PM Anuh Pharma - Quaterly Results7 Nov 2022, 3:32PM Anuh Pharma - Quaterly Results5 Aug 2022, 2:27PM Anuh Pharma - Quaterly Results5 Aug 2022, 2:27PM Anuh Pharma - Quaterly Results5 Aug 2022, 2:27PM Anuh Pharma informs about board meeting intimation 27 Jul 2022, 4:41PM Anuh Pharma informs about newspaper advertisement12 Jul 2022, 3:54PM Anuh Pharma informs about certificate7 Jul 2022, 4:58PM Anuh Pharma informs about newspaper publication16 May 2022, 2:55PM Anuh Pharma - Quaterly Results14 May 2022, 4:11PM Anuh Pharma - Quaterly Results14 May 2022, 4:11PM Anuh Pharma board to consider dividend7 May 2022, 2:24PM Anuh Pharma informs about board meeting7 May 2022, 12:28PM Anuh Pharma informs about disclosure10 Mar 2022, 3:04PM Anuh Pharma - Quaterly Results4 Feb 2022, 5:11PM Anuh Pharma - Quaterly Results4 Feb 2022, 5:11PM Anuh Pharma - Quaterly Results4 Feb 2022, 5:11PM Anuh Pharma informs about demise8 Dec 2021, 12:39PM Anuh Pharma informs about certificate8 Oct 2021, 12:08PM Anuh Pharma informs about closure of trading window24 Sep 2021, 3:18PM Anuh Pharma informs about issuance of duplicate share certificate15 Jul 2021, 3:06PM Anuh Pharma informs about newspaper advertisement8 Jul 2021, 3:32PM Anuh Pharma informs about investor presentation25 May 2021, 3:21PM Anuh Pharma informs about earnings call invite24 May 2021, 4:26PM Anuh Pharma informs about newspaper advertisement 24 May 2021, 12:25PM Anuh Pharma informs about newspaper advertisement11 May 2021, 2:18PM Anuh Pharma informs about newspaper publication regarding IEPF4 May 2021, 12:55PM Anuh Pharma gets approval for Pyrimcthamine API29 Sep 2020, 11:59AM Anuh Pharma informs about board meeting29 Jul 2020, 4:11PM Anuh Pharma informs about compliance certificate4 May 2020, 3:27PM

Anuh Pharma Stock Price Analysis and Quick Research Report. Is Anuh Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Anuh Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Anuh Pharma cash from the operating activity was Rs 53.9016 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Anuh Pharma has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Anuh Pharma , the EPS growth was 18.382907552553 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Anuh Pharma has OPM of 9.82062083164292 % which is a bad sign for profitability.
     
  • ROE: Anuh Pharma have a average ROE of 15.9033236028064 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Anuh Pharma is Rs 227.35. One can use valuation calculators of ticker to know if Anuh Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about Anuh Pharma
X